Literature DB >> 10214970

Functional role of the spatial proximity of Asp114(2.50) in TMH 2 and Asn332(7.49) in TMH 7 of the mu opioid receptor.

W Xu1, F Ozdener, J G Li, C Chen, J K de Riel, H Weinstein, L Y Liu-Chen.   

Abstract

We examined whether a proposed spatial proximity between Asp114(2.50) and Asn332(7.49) affected the functional properties of the mu opioid receptor. The D114(2.50)N mutant had reduced binding affinities for morphine, DAMGO and CTAP, but not for naloxone and [3H]diprenorphine; this mutation also abolished agonist-induced increase in [35S]GTPgammaS binding. The N332(7.49)D mutation eliminated detectable binding of either [3H]diprenorphine or [3H]DAMGO. The combined D114(2.50)N-N332(7.49)D mutation restored high affinity binding for [3H]diprenorphine, CTAP and naloxone, and restored partially the binding affinities, potencies and efficacies of morphine and DAMGO. Thus, reciprocal mutations of Asp114(2.50) and Asn332(7.49) compensate for the detrimental effects of the single mutations, indicating that the residues are adjacent in space and that their chemical functionalities are important for ligand binding and receptor activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10214970     DOI: 10.1016/s0014-5793(99)00316-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Structural domains of the CB1 cannabinoid receptor that contribute to constitutive activity and G-protein sequestration.

Authors:  J Nie; D L Lewis
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

Review 2.  Hallucinogen actions on 5-HT receptors reveal distinct mechanisms of activation and signaling by G protein-coupled receptors.

Authors:  Harel Weinstein
Journal:  AAPS J       Date:  2006-01-06       Impact factor: 4.009

Review 3.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

4.  PKA and ERK1/2 are involved in dopamine D₁ receptor-induced heterologous desensitization of the δ opioid receptor.

Authors:  Wei Xu; Chongguang Chen; Jian-Guo Li; Kelly Dimattio; Yujun Wang; Ellen Unterwald; Lee-Yuan Liu-Chen
Journal:  Life Sci       Date:  2013-04-26       Impact factor: 5.037

5.  Allosteric sodium in class A GPCR signaling.

Authors:  Vsevolod Katritch; Gustavo Fenalti; Enrique E Abola; Bryan L Roth; Vadim Cherezov; Raymond C Stevens
Journal:  Trends Biochem Sci       Date:  2014-04-21       Impact factor: 13.807

Review 6.  Harnessing Ion-Binding Sites for GPCR Pharmacology.

Authors:  Barbara Zarzycka; Saheem A Zaidi; Bryan L Roth; Vsevolod Katritch
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

7.  Protein kinase C-mediated inhibition of mu-opioid receptor internalization and its involvement in the development of acute tolerance to peripheral mu-agonist analgesia.

Authors:  H Ueda; M Inoue; T Matsumoto
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

8.  The seventh transmembrane domains of the delta and kappa opioid receptors have different accessibility patterns and interhelical interactions.

Authors:  Wei Xu; Mercedes Campillo; Leonardo Pardo; J Kim de Riel; Lee-Yuan Liu-Chen
Journal:  Biochemistry       Date:  2005-12-13       Impact factor: 3.162

9.  Exploring molecular mechanisms of ligand recognition by opioid receptors with metadynamics.

Authors:  Davide Provasi; Andrea Bortolato; Marta Filizola
Journal:  Biochemistry       Date:  2009-10-27       Impact factor: 3.162

10.  Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation.

Authors:  Yang Han; Irina S Moreira; Eneko Urizar; Harel Weinstein; Jonathan A Javitch
Journal:  Nat Chem Biol       Date:  2009-08-02       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.